Cargando…
Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis
Combination therapy has, to some extent, been successful in limiting the emergence of drug-resistant tuberculosis. Drug combinations achieve this advantage by simultaneously acting on different targets and metabolic pathways. Additionally, drug combination therapies are shown to shorten the duration...
Autores principales: | Margaryan, Hasmik, Evangelopoulos, Dimitrios D., Muraro Wildner, Leticia, McHugh, Timothy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956012/ https://www.ncbi.nlm.nih.gov/pubmed/35336089 http://dx.doi.org/10.3390/microorganisms10030514 |
Ejemplares similares
-
Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case report
por: Evangelopoulos, Dimitrios, et al.
Publicado: (2017) -
Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development
por: Evangelopoulos, Dimitrios, et al.
Publicado: (2022) -
An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis
por: Osman, Khadijo, et al.
Publicado: (2012) -
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis
por: Maitra, Arundhati, et al.
Publicado: (2020) -
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy
por: Honeyborne, Isobella, et al.
Publicado: (2016)